We can't find the internet
Attempting to reconnect
18366.1 PFLS-LS
Therapeptix ¿ Development of a Peptide-based Drug for the Treatment of Pseudomonas Biofilm Infection in Cystic Fibrosis
Résumé
Therapeptix ¿ Development of a Peptide-based Drug for the Treatment of Pseudomonas Biofilm Infection in Cystic Fibrosis
Textes supplémentaires
Abstract
This feasibility project presents a lead peptide with promising anti-biofilm properties, which we aim to develop|into a drug candidate for the treatment of Pseudomonas infection in cystic fibrosis (CF) patients. The novel|mechanism of action utilized by this drug would create a niche in the CF drug market. The intellectual property|(IP) arising from this project will serve as the basis for the establishment of a company and further|development to bring the drug to the market.
Participants
Urs Jenal
Kontaktperson
urs.jenal@unibas.ch
Universität Basel Biozentrum Urs Jenal Spitalstrasse 41 4056 Basel BS CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2016-01-31
- Date de fin
- 2017-07-31
- Coûts totaux approuvés
- CHF 352698.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%